Brief: Codiak Biosciences Reports Second Quarter 2022 Financial Results And Operational Progress
04/08/2022 21:50
Aug 4 (Reuters) - Codiak BioSciences, Inc. CDAK.O :
* CODIAK BIOSCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
AND OPERATIONAL
PROGRESS
* CODIAK BIOSCIENCES, INC. - Q2 TOTAL REVENUES $13.1 MILLION, COMPARED TO
$0.9
MILLION
Source text for Eikon: ID:nGNXc05zX8
Further company coverage: CDAK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Codiak BioSciences,.
See all newsBrief: Codiak Biosciences Notice From Listing Qualifications Department Of Nasdaq Trading Of Co's Common Stock To Be Suspended At Opening Of Business On April 5
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
U.S. STOCKS ON THE MOVE-Tesla, BrainStorm, Pinterest
Codiak BioSciences down after co files for Chapter 11 bankruptcy